Lisa Gorman, General Counsel at Eventbrite, Inc., reported a disposition of 77,483 shares of Class A Common Stock on December 19, 2025. The shares were sold at a price of $4.43 per share. This transaction, coded as 'F' (fee payment), resulted in 564,486 shares remaining in her ownership, held directly. A footnote indic...

This filing details a transaction by Graboske Benjamin, EVP, Chief Data Officer of Definitive Healthcare Corp. On December 22, 2025, Benjamin Graboske disposed of 341,417 shares of Class A Common Stock at a price of $2.53 per share, resulting in a post-transaction holding of 676,913 shares. The shares disposed of were ...

This filing details a transaction by Ashley B. Griffith, a director at BIMINI CAPITAL MANAGEMENT, INC. On December 19, 2025, Griffith acquired 50,000 shares of Class A Common Stock at a price of $1.55 per share. Following this transaction, Griffith directly owns 50,000 shares of the company's stock. The transaction cod...

Roberto Mignone, a director at Guardant Health, Inc., reported a disposition of 264 shares of Common Stock on December 21, 2025. The transaction code "M" indicates a grant, and the disposition code "D" suggests these shares were part of a Restricted Stock Unit (RSU) award. The RSUs were granted on November 8, 2024, and...

This Form 4 filing reports equity transactions by Ashoo Gupta, VP of Finance and Controller at 4D Molecular Therapeutics (FDMT), on December 20, 2025. The filing details the vesting of restricted stock units (RSUs) and related stock sales to cover tax obligations. Specifically, 866 RSUs vested and converted to common s...

This Form 4 filing details stock transactions by James Mark Harmsworth, Chief Financial Officer of HCI Group, Inc. On December 19, 2025, Mr. Harmsworth acquired 1,251 shares of Common Stock under the company's 2012 Omnibus Incentive Plan. These shares are part of a restricted stock grant with vesting scheduled over sev...

Anthony Saravanos, Division President of HCI Group, Inc., acquired 621 shares of common stock on December 19, 2025. This transaction was part of a restricted stock grant under the company's 2012 Omnibus Incentive Plan. The shares are subject to vesting conditions, with restrictions lapsing on October 23, 2026, October ...

Stephen Neeleman, Founder and Vice Chairman of HEALTHEQUITY, INC., reported a transaction on December 19, 2025. He disposed of 140,000 shares of Common Stock, valued at $0.0 per share, with the transaction noted as a bona fide gift for estate planning purposes. Concurrently, he acquired 140,000 shares of Common Stock a...

On December 19, 2025, Ladd Delano, EVP, General Counsel of HEALTHEQUITY, INC. (HQY), sold 1500 shares of common stock at a price of $94.72 per share, totaling $142,080. This transaction was executed as part of a Rule 10b5-1 trading plan adopted on June 12, 2025. Following the sale, Mr. Delano directly owns 73,979 share...

R. David Hoover, a director at Elanco Animal Health Inc., reported a transaction on December 19, 2025. The transaction involved the gift of 60,000 shares of Common Stock to a charitable trust, with a transaction price of $0.0 per share. Following this transaction, Hoover directly owns 106,773 shares and indirectly owns...

This filing details a transaction by Douglas M. Howe, CEO of Designer Brands Inc., on December 19, 2025. Howe acquired 10,546 Dividend Equivalent Rights, which are economically equivalent to Class A common shares. These rights accrued on previously awarded restricted stock units. The transaction was marked as an acquis...

G. Hunter Haas IV, Chief Financial Officer and 10% owner of BIMINI CAPITAL MANAGEMENT, INC. (BMNM), reported a transaction on December 19, 2025. Haas acquired 192,247 shares of Class A Common Stock at a price of $1.55 per share. Following this transaction, Haas directly owns 1,491,517 shares of Class A Common Stock. Th...

This filing details a transaction by Haley Mark, Interim PFO, SVP, Cntrlr & PAO of Designer Brands Inc. On December 19, 2025, Mark acquired 1004 Dividend Equivalent Rights (DERs) related to Class A Common Shares. The acquisition was non-monetary, with a transaction price of $0.00 per share. These DERs are economically ...

This Form 4 filing details stock transactions by James Mark Harmsworth, Chief Financial Officer of HCI Group, Inc. On December 19, 2025, Mr. Harmsworth acquired 1,251 shares of Common Stock under the company's 2012 Omnibus Incentive Plan. These shares are part of a restricted stock grant with vesting scheduled over sev...

This Form 4 filing details a transaction by Harper Darin, Chief Financial Officer of Dave & Buster's Entertainment, Inc. (PLAY). On December 22, 2025, Mr. Darin disposed of 1407 shares of Common Stock. The transaction code is 'F', indicating a disposition. The shares were acquired at a price of $0.0 per share. Followin...

This filing details transactions made by Julia Hartz, CEO, Director, and 10% owner of Eventbrite, Inc. (EB), on December 19, 2025. The transactions involved Class A Common Stock and Restricted Stock Units (RSUs). Notably, 6,863 RSUs, representing Class A Common Stock, were settled (transaction code M, acquired code D),...

Rebecca Hatfield, a director at Camden National Corp (CAC), acquired 171 shares of common stock on December 19, 2025, at a price of $45.95 per share. These shares were acquired under the company's 2022 Equity and Incentive Plan in lieu of director fees. Following this transaction, Hatfield now owns 7348.06 shares of co...

This Form 4 filing details transactions by Larry K. Haynes, a director at Camden National Corp. On December 19, 2025, Haynes acquired 312 shares of Common Stock under the company's 2022 Equity and Incentive Plan, in lieu of director fees. The acquisition price was $45.95 per share. Following this transaction, Haynes ho...

Jane Henderson, Chief Financial Officer of Apogee Therapeutics, Inc., reported a sale of 1500 shares of common stock on December 19, 2025. The transaction was executed at a price of $80.00 per share, resulting in a total sale value of $120,000. This sale was conducted under a Rule 10b5-1 trading plan adopted on Septemb...

This filing details a transaction by Joseph Sean-Walsh Henderson, Chief Accounting Officer of Bakkt Holdings, Inc. On December 19, 2025, Mr. Henderson sold 2,461 shares of Class A Common Stock at a price of $10.01 per share. This sale was conducted to cover tax obligations associated with the vesting of restricted stoc...

Matthew Henninger, a director at ABUNDIA GLOBAL IMPACT GROUP, INC., reported the purchase of 9,500 shares of common stock on December 19, 2025. The purchase was made through an open market transaction at a price of $1.74 per share. Following this transaction, Mr. Henninger directly owns 9,500 shares of the company's co...

This filing details a transaction by Gregory A. Hewett, a director at Acushnet Holdings Corp. On December 19, 2025, Mr. Hewett acquired 90.81 shares of Common Stock, with a transaction price of $82.45 per share. This acquisition is related to dividend equivalent rights in connection with the Issuer's quarterly dividend...

This filing details a transaction by Hill Brice, SVP, CFO of APPLIED MATERIALS INC /DE, on December 19, 2025. Brice disposed of 28,062 shares of Common Stock at a price of $256.41 per share. This transaction was made to cover tax withholding obligations upon the vesting of equity awards, as indicated by footnote F1. Fo...

This filing details transactions made by Lawrence A. Hilsheimer, EVP and CFO of Greif, Inc., on December 19, 2025. Hilsheimer disposed of a total of 1776 shares of Class A Common Stock through multiple transactions, all marked with transaction code "G" and a price per share of 0.0. These dispositions resulted in post-t...

Okupe Oluyemi, Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), reported a sale of 23,090 shares of Class A Common Stock on December 22, 2025. The shares were sold at an average weighted price of $35.7172, with prices ranging from $35.36 to $35.88. This transaction was executed as part of a Rule 10b5-1 tradi...